Recombinant Bovine Endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Bovine Endoplasmic Reticulum-Golgi Intermediate Compartment Protein 3 (ERGIC3)

Recombinant Bovine Endoplasmic Reticulum-Golgi Intermediate Compartment Protein 3 (ERGIC3) is a protein involved in the trafficking between the endoplasmic reticulum (ER) and the Golgi apparatus. While specific information on the recombinant bovine version is limited, studies on human ERGIC3 provide valuable insights into its role and potential applications. ERGIC3 is known to play a significant role in cell proliferation and metastasis, particularly in cancer cells, where ER to Golgi trafficking is elevated .

Function and Role of ERGIC3

ERGIC3 is part of the ER-Golgi intermediate compartment, which is crucial for protein modification, sorting, and transport. In cancer cells, enhanced ER to Golgi trafficking contributes to increased cell growth and epithelial-mesenchymal transition, leading to poor prognosis in lung cancer . Knockdown of ERGIC3 has been shown to induce ER stress, leading to autophagic cell death and suppression of proliferation in lung cancer cells .

Impact on Lung Cancer

  • Cell Proliferation and Metastasis: ERGIC3 promotes cell proliferation and metastasis in lung cancer. Its knockdown results in reduced cell growth and increased ER stress-induced autophagy .

  • Protein Interactions: ERGIC3 interacts with proteins involved in cytoskeleton construction and RHO GTPases activated p21-activated kinases, influencing cellular processes .

Proteomic Analysis

Protein TypeUp-regulatedDown-regulated
Intracellular3319
Extracellular4147

After ERGIC3 knockdown, significant changes in intracellular and extracellular proteins were observed, with extracellular proteins mainly involved in Ca²⁺ binding and transport, and intracellular proteins involved in histone methylation processes .

Therapeutic Potential

ERGIC3's role in cancer progression makes it a potential therapeutic target. Studies have shown that suppressing ERGIC3 can inhibit lung tumorigenesis, suggesting its utility in developing cancer therapies .

References Changes in intracellular and extracellular proteins after ERGIC3 knockdown in lung cancer: Proteins interacting with ERGIC3, HORN, and FLNA. Endoplasmic reticulum-Golgi intermediate compartment protein 3 suppresses cell proliferation and tumor growth in lung cancer. ERGIC3 and its role in lung cancer. ERGIC3 is a novel immune function-related gene. ERGIC3 as a potential biomarker. ER-Golgi intermediate compartment proteins in cancer treatment. ERGIC3 gene information. The endoplasmic reticulum—Golgi intermediate compartment.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
ERGIC3; Endoplasmic reticulum-Golgi intermediate compartment protein 3
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-383
Protein Length
full length protein
Species
Bos taurus (Bovine)
Target Names
ERGIC3
Target Protein Sequence
MEALGKLKQFDAYPKTLEDFRVKTCGGATVTIVSGLLMLLLFLSELQYYLTTEVHPELYV DKSRGDKLKININVLFPHMPCAYLSIDAMDVAGEQQLDVEHNLFKKRLDKDGFPVSSEAE RHELGKVEVKVFDPDSLDPDRCESCYGAEMEDIKCCNSCEDVREAYRRRGWAFKNPDTIE QCRREGFSQKMQEQKNEGCQVYGFLEVNKVAGNFHFAPGKSFQQSHVHVHDLQSFGLDNI NMTHYIRHLSFGEDYPGIVNPLDHTNVTAPQASMMFQYFVKVVPTVYMKVDGEVLRTNQF SVTRHEKVANGLMGDQGLPGVFVLYELSPMMVKLTEKHRSFTHFLTGVCAIIGGMFTVAG LIDSLIYHSARAIQKKIDLGKTT
Uniprot No.

Target Background

Function

Function: Potentially involved in the transport of proteins between the endoplasmic reticulum and the Golgi apparatus.

Database Links

KEGG: bta:509546

UniGene: Bt.6352

Protein Families
ERGIC family
Subcellular Location
Endoplasmic reticulum-Golgi intermediate compartment membrane; Multi-pass membrane protein. Golgi apparatus, cis-Golgi network membrane; Multi-pass membrane protein. Endoplasmic reticulum membrane; Multi-pass membrane protein.

Q&A

What is the fundamental role of ERGIC3 in cellular trafficking?

ERGIC3 functions as a cargo receptor in the early secretory pathway, participating in bidirectional protein trafficking between the ER and Golgi. It works in concert with other cargo receptors such as Surf4 and p25 to maintain the structural integrity of the ER-Golgi intermediate compartment (ERGIC) and Golgi apparatus .

Research indicates that ERGIC3 and related cargo receptors are essential for:

  • Stabilizing ERGIC membrane clusters

  • Mediating proper coat protein I (COPI) recruitment to membranes

  • Maintaining the architecture of the Golgi apparatus

  • Supporting efficient retrograde trafficking

The protein appears to be particularly important for maintaining the tubular-vesicular network structure of the ERGIC and the ribbon-like morphology of the Golgi complex.

How should recombinant bovine ERGIC3 be reconstituted and stored for maximum stability?

For optimal stability and experimental reproducibility when working with recombinant bovine ERGIC3:

  • Reconstitution protocol:

    • Centrifuge the lyophilized protein vial briefly before opening

    • Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL

    • Add glycerol to a final concentration of 5-50% (50% is recommended)

    • Aliquot to minimize freeze-thaw cycles

  • Storage conditions:

    • Long-term storage: -20°C to -80°C in aliquots

    • Working stock: 4°C for up to one week

    • Avoid repeated freeze-thaw cycles as they significantly reduce protein activity

  • Buffer composition:

    • Standard storage buffer typically consists of Tris/PBS-based buffer containing 6% trehalose at pH 8.0

What imaging approaches are most effective for studying ERGIC3 dynamics?

Several imaging approaches have proven effective for studying ERGIC3 and the dynamic nature of the ERGIC compartment:

  • Live cell imaging with GFP fusion constructs:

    • GFP-ERGIC53 has been successfully used as a marker for the ERGIC compartment

    • This approach enables real-time visualization of bidirectional traffic from the ERGIC

  • Confocal laser scanning microscopy:

    • Particularly effective for co-localization studies with other organelle markers

    • Use antibodies against β-COP to visualize COPI structures

    • Co-staining with giantin antibodies helps distinguish the Golgi region

  • Quantification methodology:

    • For quantifying ERGIC clusters, stain for KDEL-receptor and subtract the Golgi area (identified by giantin staining)

    • Use image analysis software (e.g., Image-Pro Plus) to count ERGIC clusters

    • For accurate β-COP staining quantification, use CCD camera imaging with a high-quality microscope

When designing experiments, ensure proper controls to distinguish the ERGIC from the ER and Golgi compartments, as their proximity can complicate interpretation of results.

How does ERGIC3 knockdown affect cellular structure and function?

ERGIC3 knockdown produces significant structural and functional alterations:

ParameterEffect of ERGIC3 KnockdownMeasurement Method
ERGIC morphologyReduced number of ERGIC clustersImmunofluorescence with KDEL-receptor antibody
Golgi structureFragmentation into mini-stacksGiantin staining
COPI localizationPartial redistribution to cytosolβ-COP immunostaining
ER stressIncreasedUPR marker expression analysis
AutophagyEnhanced autophagic cell deathLC3 conversion assay
Cell proliferationSuppressed (in cancer cells)Growth curve analysis

Mechanistically, ERGIC3 knockdown leads to ER stress-induced autophagic cell death in lung cancer cells, suggesting its potential as a therapeutic target . The structural effects are attributed to impaired COPI recruitment to membranes, which disrupts normal retrograde trafficking within the early secretory pathway .

What are effective methods for ERGIC3 knockdown in experimental models?

Based on published research, several effective approaches for ERGIC3 knockdown include:

  • shRNA-mediated knockdown:

    • Short hairpin RNA targeting ERGIC3 (shERGIC3) has been successfully used

    • Can be delivered via lentiviral vectors for stable knockdown

    • For in vivo applications, non-invasive aerosol delivery using biocompatible carriers like glycerol propoxylate triacrylate and spermine (GPT-SPE) has proven effective

  • siRNA transient knockdown:

    • Useful for short-term studies

    • Often combined with other cargo receptor knockdowns (e.g., Surf4) to enhance phenotypes

  • Validation methods:

    • Western blot analysis to confirm protein reduction

    • qRT-PCR for mRNA level verification

    • Immunofluorescence microscopy to assess morphological changes

    • Functional assays to confirm physiological impact

When designing knockdown experiments, consider that simultaneous knockdown of multiple cargo receptors (e.g., ERGIC3 with Surf4 or p25) may produce more pronounced phenotypes due to functional redundancy in the early secretory pathway .

How does ERGIC3 contribute to cancer biology and what are its therapeutic implications?

ERGIC3 has emerged as a significant factor in cancer biology, particularly in lung cancer:

  • Role in cancer progression:

    • Trafficking from ER to Golgi is elevated in cancer cells

    • ERGIC3 expression correlates with enhanced cancer cell growth

    • Associated with epithelial-mesenchymal transition (EMT)

    • High expression correlates with poor prognosis in lung cancer

  • Therapeutic targeting:

    • ERGIC3 knockdown leads to ER stress-induced autophagic cell death

    • Suppresses proliferation in human lung cancer cell lines like A549

    • In vivo studies using K-rasLA1 murine lung cancer models show that aerosol delivery of shERGIC3 inhibits lung tumorigenesis

  • Mechanism of action:

    • ERGIC3 suppression appears to induce ER stress

    • Activated unfolded protein response (UPR) leads to autophagic cell death

    • Disrupts the elevated ER-Golgi trafficking that cancer cells depend on

This research suggests that ERGIC3 could be a promising target for developing novel lung cancer therapies, particularly through gene therapy approaches targeting its expression.

How does ERGIC3 interact with other cargo receptors in maintaining cellular architecture?

ERGIC3 functions within a network of cargo receptors that collectively maintain ERGIC and Golgi architecture:

  • Interaction partners:

    • ERGIC3 interacts with ERGIC-53 and p24 family proteins

    • These interactions are crucial for stabilizing membrane structures

    • Together they coordinate proper COPI recruitment

  • Structural maintenance mechanisms:

    • Cargo receptors like ERGIC3 contain dilysine signals in their cytosolic tails

    • These signals directly interact with COPI subunits

    • Combined knockdown of Surf4/ERGIC-53 or p25 reduces COPI binding

    • This leads to identical phenotypes characterized by Golgi fragmentation and reduced ERGIC clusters

  • Functional redundancy:

    • Individual knockdown of cargo receptors often produces limited phenotypes

    • Combined knockdown reveals their essential roles in maintaining organelle architecture

    • This redundancy likely ensures robust maintenance of the early secretory pathway

The research demonstrates that cargo receptors like ERGIC3 are not only important for specific cargo transport but also play structural roles that are critical for maintaining the integrity of the early secretory pathway.

What controls are essential when studying ERGIC3 function in cellular assays?

When designing experiments to study ERGIC3 function, the following controls are essential:

  • For knockdown studies:

    • Non-targeting shRNA/siRNA controls with similar GC content

    • Single cargo receptor knockdowns to compare with combined knockdowns

    • Rescue experiments with shRNA/siRNA-resistant ERGIC3 constructs

    • Time course analysis to distinguish primary from secondary effects

  • For localization studies:

    • Co-staining with markers for ER (e.g., PDI), ERGIC (e.g., ERGIC-53), and Golgi (e.g., giantin)

    • Include quantification of organelle morphology and number

    • Validation with multiple antibodies or tagged constructs

  • For functional assays:

    • Cargo transport assays to assess secretory pathway function

    • ER stress markers (e.g., BiP, CHOP) to monitor UPR activation

    • Cell viability assessments using multiple methods (e.g., MTT, annexin V)

  • For in vivo studies:

    • Vehicle-only controls using identical delivery methods

    • Non-targeting shRNA delivered with the same carrier

    • Careful monitoring of potential off-target effects

What are the current technical challenges in studying ERGIC3 and how can they be addressed?

Several technical challenges exist in studying ERGIC3, with potential solutions:

  • Distinguishing direct vs. indirect effects:

    • Challenge: ERGIC3 knockdown affects multiple cellular processes

    • Solution: Use inducible knockdown systems to monitor immediate effects

    • Perform careful time course experiments to establish causal relationships

  • Functional redundancy among cargo receptors:

    • Challenge: Single knockdowns often show limited phenotypes

    • Solution: Design combined knockdown approaches targeting multiple cargo receptors

    • Use domain-specific mutations rather than complete knockdowns

  • Dynamic nature of the ERGIC compartment:

    • Challenge: ERGIC is highly dynamic and difficult to isolate

    • Solution: Employ live cell imaging with photoactivatable or photoswitchable tags

    • Use super-resolution microscopy for better spatial resolution

  • Antibody specificity issues:

    • Challenge: Limited availability of specific antibodies against bovine ERGIC3

    • Solution: Use epitope-tagged recombinant proteins

    • Validate antibodies across multiple applications and cell types

  • Physiological relevance of in vitro findings:

    • Challenge: Translating cell culture findings to in vivo systems

    • Solution: Develop tissue-specific knockout models

    • Use advanced delivery systems like aerosol delivery for lung-specific studies

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.